PL352862A1 - Tricykliczne związki posiadające połączenie spiro - Google Patents

Tricykliczne związki posiadające połączenie spiro

Info

Publication number
PL352862A1
PL352862A1 PL00352862A PL35286200A PL352862A1 PL 352862 A1 PL352862 A1 PL 352862A1 PL 00352862 A PL00352862 A PL 00352862A PL 35286200 A PL35286200 A PL 35286200A PL 352862 A1 PL352862 A1 PL 352862A1
Authority
PL
Poland
Prior art keywords
spiro union
tricyclic compounds
useful
relates
inhibitor
Prior art date
Application number
PL00352862A
Other languages
English (en)
Inventor
Hidemitsu Nishida
Fumihiko Saitoh
Kousuke Harada
Ikuya Shiromizu
Original Assignee
Mochida Pharmaceutical Co, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharmaceutical Co, Ltd. filed Critical Mochida Pharmaceutical Co, Ltd.
Publication of PL352862A1 publication Critical patent/PL352862A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/20—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96444—Factor X (3.4.21.6)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Prostheses (AREA)
  • External Artificial Organs (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL00352862A 1999-06-30 2000-06-30 Tricykliczne związki posiadające połączenie spiro PL352862A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP22288399 1999-06-30
PCT/JP2000/004374 WO2001002397A1 (en) 1999-06-30 2000-06-30 Tricyclic compounds having spiro union

Publications (1)

Publication Number Publication Date
PL352862A1 true PL352862A1 (pl) 2003-09-08

Family

ID=16789385

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00352862A PL352862A1 (pl) 1999-06-30 2000-06-30 Tricykliczne związki posiadające połączenie spiro

Country Status (21)

Country Link
EP (1) EP1191028B1 (pl)
JP (1) JP4890707B2 (pl)
KR (1) KR20020015061A (pl)
CN (1) CN1371375A (pl)
AT (1) ATE281457T1 (pl)
AU (1) AU774397B2 (pl)
BR (1) BR0012093A (pl)
CA (1) CA2380852C (pl)
CZ (1) CZ20014696A3 (pl)
DE (1) DE60015541T2 (pl)
HK (1) HK1049157A1 (pl)
HU (1) HUP0202188A3 (pl)
IL (1) IL147348A0 (pl)
MX (1) MXPA02000003A (pl)
NO (1) NO20016402L (pl)
NZ (1) NZ516363A (pl)
PL (1) PL352862A1 (pl)
SK (1) SK19292001A3 (pl)
TR (1) TR200103853T2 (pl)
WO (1) WO2001002397A1 (pl)
ZA (1) ZA200110558B (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1302462A4 (en) * 2000-07-17 2007-07-18 Takeda Pharmaceutical SULFONATE DERIVATIVES, PROCESS FOR PRODUCTION AND USE THEREOF
WO2002053568A1 (en) * 2000-12-28 2002-07-11 Mochida Pharmaceutical Co., Ltd. Cholesterol biosynthesis inhibitors containing as the active ingredient tricyclic spiro compounds
CN100513398C (zh) 2002-12-03 2009-07-15 Axys药物公司 作为因子viia抑制剂的2-(2-羟基联苯-3-基)-1h-苯并咪唑-5-甲脒衍生物
TWI396686B (zh) 2004-05-21 2013-05-21 Takeda Pharmaceutical 環狀醯胺衍生物、以及其製品和用法
WO2006006490A1 (ja) * 2004-07-08 2006-01-19 Ono Pharmaceutical Co., Ltd. スピロ化合物
WO2006106804A1 (ja) 2005-03-31 2006-10-12 Mochida Pharmaceutical Co., Ltd. 環内窒素原子にアシル基が結合した三環系スピロ化合物
WO2007136085A1 (ja) 2006-05-23 2007-11-29 Mochida Pharmaceutical Co., Ltd. スピロ四環系化合物
US7739434B2 (en) 2008-01-11 2010-06-15 International Business Machines Corporation Performing a configuration virtual topology change and instruction therefore

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0300541B1 (en) * 1987-07-20 1996-03-27 Duphar International Research B.V 8,9-anellated-1,2,3,4-tetrahydro-beta-carboline derivatives
US5292747A (en) * 1990-08-07 1994-03-08 Hoffman-La Roche Inc. Substituted pyrroles

Also Published As

Publication number Publication date
CA2380852A1 (en) 2001-01-11
MXPA02000003A (es) 2003-07-21
DE60015541T2 (de) 2005-12-08
HUP0202188A2 (en) 2002-10-28
CZ20014696A3 (cs) 2002-05-15
DE60015541D1 (de) 2004-12-09
AU5572000A (en) 2001-01-22
WO2001002397A1 (en) 2001-01-11
EP1191028A4 (en) 2002-10-23
NZ516363A (en) 2004-05-28
HK1049157A1 (zh) 2003-05-02
EP1191028A1 (en) 2002-03-27
ZA200110558B (en) 2002-09-12
NO20016402D0 (no) 2001-12-28
WO2001002397A9 (en) 2001-04-05
EP1191028B1 (en) 2004-11-03
AU774397B2 (en) 2004-06-24
BR0012093A (pt) 2002-07-16
KR20020015061A (ko) 2002-02-27
ATE281457T1 (de) 2004-11-15
TR200103853T2 (tr) 2002-11-21
NO20016402L (no) 2002-02-27
SK19292001A3 (sk) 2002-06-04
CA2380852C (en) 2009-10-20
IL147348A0 (en) 2002-08-14
JP4890707B2 (ja) 2012-03-07
CN1371375A (zh) 2002-09-25
HUP0202188A3 (en) 2004-04-28

Similar Documents

Publication Publication Date Title
ATE260255T1 (de) 5-oxo-pyrrolidine-2-carbonsäure- hydroxamidderivate
DE69615674D1 (de) Cyclobutan-derivate als inhibitoren der squalen-synthase und der protein farnesyltransferase
ATE540928T1 (de) Isochinolinverbindungen und ihre medizinische verwendung
EA200800485A1 (ru) Макроциклические ингибиторы вируса гепатита с
WO2001019776A3 (de) Neuartige dicarbonsäurederivate mit pharmazeutischen eigenschaften
WO2000061568A8 (de) Mit zuckerresten substituierte 1,4-benzothiazepin-1,1-dioxidderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
AU2001232287A1 (en) Novel pyrazine derivatives or salts thereof, pharmaceutical compositions containing the derivatives or the salts and intermediates for the preparation of both
ATE453393T1 (de) Verwendung von pyridylamiden als angiogenesehemmer
BR0314688A (pt) Novos derivados de piperidina para utilização no tratamento de estados de doença mediados pela quimiocina
EA200301216A1 (ru) Замещенные хинуклидинами мультициклические гетероарилы для лечения заболевания
DE60226764D1 (de) Substituierte heteroarylalkansäure und ihre verwendung als inhibitoren der aldose reductase
ATE377602T1 (de) Morphinanderivate und ihre medizinische anwendung
MY139461A (en) Condensed furan compounds
BRPI0606480A (pt) compostos farmacêuticos
IL147348A0 (en) Tricyclic compounds having spiro union
DE60122555D1 (de) Spiroverbindungen und diese als wirkstoff enthaltende adhäsionsmolekülinhibitoren
PT1043310E (pt) Derivados de bifenilamidina
WO2006012395A3 (en) Peptidase inhibitors
WO2003082192A3 (en) Certain pharmaceutically useful substituted aminoalkyl heterocycles
WO2002026732A1 (en) Benzodiazepine derivative
MY129094A (en) Condensed polycyclic compounds
AU2002339158A1 (en) 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors
DE60013515D1 (de) 4-Arylpiperidinderivate zur Behandlung von Pruritus
TH70879A (th) อนุพันธ์ของ 5-(ไพริดิน-3-อิล)-1-แอซาไบไซโคล[3.2.1]ออกเทน, การเตรียมสาร และการประยุกต์ใช้สารในการบำบัดรักษา

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)